Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • Persone
  • Pubblicazioni
  • Facoltà
  • Ambiti Di Ricerca

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • Persone
  • Pubblicazioni
  • Facoltà
  • Ambiti Di Ricerca
  1. Pubblicazioni

THE LANCET. RHEUMATOLOGY

Rivista
Codice:
E255857
ISSN:
2665-9913
  • Dati Generali

Dati Generali

Pubblicazioni (22)

  • ascendente
  • decrescente
Anakinra for patients with COVID-19 – Authors' reply
Articolo
Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine
Articolo
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study
Articolo
Cutaneous vasculitis following COVID-19 vaccination
Articolo
Effect of anakinra in COVID-19 - Authors' reply.
Articolo
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis
Articolo
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study
Articolo
Granulocyte-macrophage colony stimulating factor in COVID-19: friend or foe?
Articolo
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19
Articolo
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Articolo
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study
Articolo
Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply
Articolo
Mavrilimumab for severe COVID-19 – Authors' reply
Articolo
Pre-scleroderma and new opportunities for preventive medicine – Authors’ reply
Articolo
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS)
Articolo
Proliferative features of IgG4-related disease
Articolo
Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease
Articolo
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial
Articolo
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort
Articolo
The conundrum of interleukin-6 blockade in COVID-19
Articolo
The multifaceted problem of pulmonary arterial hypertension in systemic sclerosis
Articolo
The role of skin ultrasound in systemic sclerosis: looking below the surface to understand disease evolution
Articolo
No Results Found
  • «
  • ‹
  • {pageNumber}
  • ›
  • »
{startItem} - {endItem} di {itemsNumber}
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.0.0